230 related articles for article (PubMed ID: 36551144)
21. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
22. Patient-Specific Microfluidic Cancer Spheroid Cultures for Testing Cancer Therapies.
Choi D; Gonzalez-Suarez AM; Billadeau DD; Ma WW; Stybayeva G; Revzin A
Methods Mol Biol; 2023; 2679():219-231. PubMed ID: 37300619
[TBL] [Abstract][Full Text] [Related]
23. Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma.
Wang B; Xue Y; Zhai W
Front Immunol; 2022; 13():902060. PubMed ID: 35592336
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid.
Tanaka C; Furihata K; Naganuma S; Ogasawara M; Yoshioka R; Taniguchi H; Furihata M; Taniuchi K
Hum Cell; 2022 Mar; 35(2):735-744. PubMed ID: 35150409
[TBL] [Abstract][Full Text] [Related]
25. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
26. Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system.
Bas-Cristóbal Menéndez A; Du Z; van den Bosch TPP; Othman A; Gaio N; Silvestri C; Quirós W; Lin H; Korevaar S; Merino A; Mulder J; Hoogduijn MJ
Sci Rep; 2022 Nov; 12(1):20699. PubMed ID: 36450835
[TBL] [Abstract][Full Text] [Related]
27. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity.
Jiang S; Zhao H; Zhang W; Wang J; Liu Y; Cao Y; Zheng H; Hu Z; Wang S; Zhu Y; Wang W; Cui S; Lobie PE; Huang L; Ma S
Cell Rep Med; 2020 Dec; 1(9):100161. PubMed ID: 33377132
[TBL] [Abstract][Full Text] [Related]
28. Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro.
Sun G; Ding B; Wan M; Chen L; Jackson J; Atala A
Stem Cell Res Ther; 2020 Jul; 11(1):309. PubMed ID: 32698872
[TBL] [Abstract][Full Text] [Related]
29. Cancer research using organoid technology.
Kretzschmar K
J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
[TBL] [Abstract][Full Text] [Related]
30. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
31. Microfluidics and Organoids, the Power Couple of Developmental Biology and Oncology Studies.
Hetzel LA; Ali A; Corbo V; Hankemeier T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446057
[TBL] [Abstract][Full Text] [Related]
32. Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis.
Lee J; Jung S; Hong HK; Jo H; Rhee S; Jeong YL; Ko J; Cho YB; Jeon NL
Lab Chip; 2024 Apr; 24(8):2208-2223. PubMed ID: 38533822
[TBL] [Abstract][Full Text] [Related]
33. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
[TBL] [Abstract][Full Text] [Related]
34. Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology In Vitro.
Ding B; Sun G; Liu S; Peng E; Wan M; Chen L; Jackson J; Atala A
Cell Transplant; 2020; 29():963689719897066. PubMed ID: 32166969
[TBL] [Abstract][Full Text] [Related]
35. Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip.
Lee HN; Choi YY; Kim JW; Lee YS; Choi JW; Kang T; Kim YK; Chung BG
Nano Converg; 2021 Nov; 8(1):35. PubMed ID: 34748091
[TBL] [Abstract][Full Text] [Related]
36. Human Spinal Organoid-on-a-Chip to Model Nociceptive Circuitry for Pain Therapeutics Discovery.
Ao Z; Cai H; Wu Z; Krzesniak J; Tian C; Lai YY; Mackie K; Guo F
Anal Chem; 2022 Jan; 94(2):1365-1372. PubMed ID: 34928595
[TBL] [Abstract][Full Text] [Related]
37. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
38. Hydrogel Mechanics Influence the Growth and Development of Embedded Brain Organoids.
Cassel de Camps C; Aslani S; Stylianesis N; Nami H; Mohamed NV; Durcan TM; Moraes C
ACS Appl Bio Mater; 2022 Jan; 5(1):214-224. PubMed ID: 35014820
[TBL] [Abstract][Full Text] [Related]
39. Organoid technology in female reproductive biomedicine.
Heidari-Khoei H; Esfandiari F; Hajari MA; Ghorbaninejad Z; Piryaei A; Baharvand H
Reprod Biol Endocrinol; 2020 Jun; 18(1):64. PubMed ID: 32552764
[TBL] [Abstract][Full Text] [Related]
40. Assay establishment and validation of a high-throughput organoid-based drug screening platform.
Li X; Fu G; Zhang L; Guan R; Tang P; Zhang J; Rao X; Chen S; Xu X; Zhou Y; Deng Y; Lv T; He X; Mo S; Mu P; Gao J; Hua G
Stem Cell Res Ther; 2022 May; 13(1):219. PubMed ID: 35619149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
